May 11, 2023
The U.S. Drug Enforcement Administration (DEA) is extending the ability for physicians to prescribe controlled substances based on telehealth visits through November 11, 2023. This method had been set to expire when the COVID-19 Public Health Emergency ended today (May 11).
On March 1, the DEA and the Department of Health and Human Services (HHS), sent out notices of proposed rulemakings (NPRMs) to generate feedback on proposals to continue allowing the prescribing of controlled medications via virtual visits with patients. More than 38,000 public comments came in.
“These medications, including those used to treat opioid use disorder, are a vital form of care for millions of Americans who have come to rely on safe and effective telemedicine appointments,” said the AMA in a statement. “Patients being treated with these medications often have challenges securing and traveling to in-person appointments.”
October 8, 2026
On September 29, a Hennepin County jury issued an $84 million malpractice verdict against Fairview Health Services, in a case involving a patient who died of complications following an exercise-induced heart attack.
October 8, 2026
A group of fifth-grade students from Lincoln Elementary School in St. Cloud got a firsthand look at the world of medicine on October 5, during a special Mini Medical School Day hosted by the University of Minnesota Medical School CentraCare Regional Campus St. Cloud.
October 8, 2026
On October 7, the MMA released an updated version of its “The One Big Beautiful Bill Act (OBBBA) Resource Guide for Physicians.”